… SARS-CoV-2 neutralizing antibodies described in this manuscript. Both sets of applications
are under review. DDH is a co-founder of TaiMed Biologics and RenBio, consultant to WuXi …

… SARS-CoV-2 neutralizing antibodies described in this manuscript. Both sets of applications
are under review. DDH is a co-founder of TaiMed Biologics and RenBio, consultant to WuXi …

… of SARS-CoV-2 by naturally or vaccine-induced antibody … its interactions with serum and
antibodies with those of three other … sera induced by infection with early strains of SARS-CoV-2 ( …

… of SARS-CoV-2 Omicron are now rapidly expanding, possibly due to altered antibody evasion
… Monoclonal antibodies capable of neutralizing the original Omicron variant were largely …

… SARS-CoV-2 continues to evolve, successively yielding subvariants that are not only more
transmissible but also more evasive to antibodies… by SARS-CoV-2 neutralizing antibodies. d,e…

… If circulating antibodies disappear over time, data suggest … quick source of protective antibody
in the case of potential SARS-CoV-2 re… of antibody therapies in SARS-CoV-2 infection [54]. …

… the SARS-CoV spike protein to isolate a neutralizing antibody … N-linked glycan acquisition
by the SARS-CoV-2 RBD confers … -reactive antibody and at least one other antibody that binds …

… Given the importance of understanding the evolution of resistance to mAbs by SARS-CoV-2, …
Unfortunately, evasion of mAb-induced protection is being reported with new SARS-CoV-2 …

… The SARS-CoV-2 Omicron variant has evolved … antibody evasion of BA.1 and BA.2, but
side-by-side comparisons of Omicron sub-lineages to vaccine-elicited or monoclonal antibody (…

… the capacity of Omicron to evade immunity from neutralizing antibodies, produced by natural
… immune evasion capacity of SARS-CoV-2, with an emphasis on the neutralizing antibodies …